CytoDyn Market Cap

CytoDyn has a market cap or net worth of $403.93 million as of December 5, 2025. Its market cap has increased by 181.29% in one year.

Market Cap

403.93M

Enterprise Value

421.90M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.32

Market Cap Chart

Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 403.93M, an increase of 7,194.36%. That is a compound annual growth rate of 23.84%.

Market Cap History

Date	Market Cap	% Change
Dec 4, 2025	403.93M	200.02%
Dec 31, 2024	134.63M	-29.42%
Dec 29, 2023	190.74M	2.63%
Dec 30, 2022	185.85M	-72.64%
Dec 31, 2021	679.28M	-78.86%
Dec 31, 2020	3.21B	695.20%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Veradigm	815.80M
Elite Pharmaceuticals	558.58M
Glass House Brands	531.36M
American Oncology Network	367.13M
Northwest Biotherapeutics	364.92M
Silence Therapeutics	336.78M
Nika Pharmaceuticals	259.91M
HST Global	131.71M

Market Cap Rankings